Pliva-Lachema A.S.
Records under this name other than patents Pliva-Lachema A.S. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Pliva-Lachema A.S.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,767,709 | Pharmaceutical composition for oral administration Formerly held In force · USPTO record | In force | USPTO record | |
| US 6,503,943 | Platinum complex, its preparation and therapeutic application Lapsed on the fee record Ended Jan 7, 2015 · USPTO record | Lapsed on the fee record | Ended Jan 7, 2015 | USPTO record |
| US 6,350,737 | Platinum complex, its preparation and therapeutic application Lapsed on the fee record Ended Feb 26, 2014 · USPTO record | Lapsed on the fee record | Ended Feb 26, 2014 | USPTO record |
| US 7,655,697 | Oral pharmaceutical composition for targeted transport of a platinum complex into the colorectal region, method for producing and use as medicament thereof Lapsed on the fee record Ended Feb 2, 2014 · USPTO record | Lapsed on the fee record | Ended Feb 2, 2014 | USPTO record |
| US 7,544,801 | Method of manufacturing of 7-ethyl-10-hydroxycamptothecin Formerly held Lapsed on the fee record Ended Jun 9, 2013 · USPTO record | Lapsed on the fee record | Ended Jun 9, 2013 | USPTO record |
| US 7,507,825 | Method of manufacturing of 7-ethyl-10-[4-(1-piperidino)-1- piperidino]- carbonyloxy- camptothecin Formerly held Lapsed on the fee record Ended Mar 24, 2013 · USPTO record | Lapsed on the fee record | Ended Mar 24, 2013 | USPTO record |
| US 7,351,846 | Oxaliplatin with a low content of accompanying impurities and a method for preparation thereof Lapsed on the fee record Ended Apr 1, 2012 · USPTO record | Lapsed on the fee record | Ended Apr 1, 2012 | USPTO record |
| US 6,589,988 | Pharmaceutical composition with antitumor activity on the basis of carboplatin Lapsed on the fee record Ended Jul 8, 2011 · USPTO record | Lapsed on the fee record | Ended Jul 8, 2011 | USPTO record |